TITAN PHARMACEUTICALS INC - Director's Dealing 2010

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP:PK)
CIK: 0000910267
Period of Report: 2010-03-15

Reporting Person: Cavalier Eurelio M (Director)

Security	Shares	Ownership
Common Stock, $0.001 par value per share	182500	Direct

Security	Exercise Price	Expiration	Underlying	Ownership
Option to Purchase Common Stock	$43.625	2010-08-28	Common Stock (20000)	Direct
Option to Purchase Common Stock	$11.63	2011-08-09	Common Stock (15000)	Direct
Option to Purchase Common Stock	$11.50	2011-08-10	Common Stock (5000)	Direct
Option to Purchase Common Stock	$3.79	2012-06-15	Common Stock (3036)	Direct
Option to Purchase Common Stock	$3.45	2012-06-15	Common Stock (16964)	Direct
Option to Purchase Common Stock	$1.71	2002-08-16	Common Stock (25000)	Direct
Option to Purchase Common Stock	$3.29	2013-10-31	Common Stock (10000)	Direct
Option to Purchase Common Stock	$2.37	2014-09-01	Common Stock (30000)	Direct
Option to Purchase Common Stock	$2.05	2015-08-09	Common Stock (15000)	Direct
Option to Purchase Common Stock	$1.40	2016-01-03	Common Stock (5000)	Direct
Option to Purchase Common Stock	$2.35	2016-08-29	Common Stock (20000)	Direct
Option to Purchase Common Stock	$2.48	2016-09-05	Common Stock (15000)	Direct
Option to Purchase Common Stock	$2.04	2017-09-24	Common Stock (15000)	Direct
Option to Purchase Common Stock	$1.52	2018-05-30	Common Stock (25000)	Direct
Option to Purchase Common Stock	$0.79	2019-05-17	Common Stock (25000)	Direct

F1: These options vest in 48 equal monthly installments beginning on August 29, 2006.

F2: These options vest in 12 equal monthly installments beginning on May 17, 2009.